FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387296852> ?p ?o ?g. }

• W4387296852 endingPage "1255" @default.
• W4387296852 startingPage "1255" @default.
• W4387296852 abstract "Importance The effect of continuous positive airway pressure (CPAP) on secondary cardiovascular disease prevention is highly debated. Objective To assess the effect of CPAP treatment for obstructive sleep apnea (OSA) on the risk of adverse cardiovascular events in randomized clinical trials. Data Sources PubMed (MEDLINE), EMBASE, Current Controlled Trials: metaRegister of Controlled Trials, ISRCTN Registry, European Union clinical trials database, CENTRAL (Cochrane Central Register of Controlled Trials), and ClinicalTrials.gov databases were systematically searched through June 22, 2023. Study Selection For qualitative and individual participant data (IPD) meta-analysis, randomized clinical trials addressing the therapeutic effect of CPAP on cardiovascular outcomes and mortality in adults with cardiovascular disease and OSA were included. Data Extraction and Synthesis Two reviewers independently screened records, evaluated potentially eligible primary studies in full text, extracted data, and cross-checked errors. IPD were requested from authors of the selected studies (SAVE [ NCT00738179 ], ISAACC [ NCT01335087 ], and RICCADSA [ NCT00519597 ]). Main Outcomes and Measures One-stage and 2-stage IPD meta-analyses were completed to estimate the effect of CPAP treatment on risk of recurrent major adverse cardiac and cerebrovascular events (MACCEs) using mixed-effect Cox regression models. Additionally, an on-treatment analysis with marginal structural Cox models using inverse probability of treatment weighting was fitted to assess the effect of good adherence to CPAP (≥4 hours per day). Results A total of 4186 individual participants were evaluated (82.1% men; mean [SD] body mass index, 28.9 [4.5]; mean [SD] age, 61.2 [8.7] years; mean [SD] apnea-hypopnea index, 31.2 [17] events per hour; 71% with hypertension; 50.1% receiving CPAP [mean {SD} adherence, 3.1 {2.4} hours per day]; 49.9% not receiving CPAP [usual care], mean [SD] follow-up, 3.25 [1.8] years). The main outcome was defined as the first MACCE, which was similar for the CPAP and no CPAP groups (hazard ratio, 1.01 [95% CI, 0.87-1.17]). However, an on-treatment analysis by marginal structural model revealed a reduced risk of MACCEs associated with good adherence to CPAP (hazard ratio, 0.69 [95% CI, 0.52-0.92]). Conclusions and Relevance Adherence to CPAP was associated with a reduced MACCE recurrence risk, suggesting that treatment adherence is a key factor in secondary cardiovascular prevention in patients with OSA." @default.
• W4387296852 created "2023-10-04" @default.
• W4387296852 creator A5004568141 @default.
• W4387296852 creator A5004937795 @default.
• W4387296852 creator A5005472573 @default.
• W4387296852 creator A5005538880 @default.
• W4387296852 creator A5012551681 @default.
• W4387296852 creator A5015960013 @default.
• W4387296852 creator A5022592999 @default.
• W4387296852 creator A5024243963 @default.
• W4387296852 creator A5029438535 @default.
• W4387296852 creator A5030022395 @default.
• W4387296852 creator A5034543902 @default.
• W4387296852 creator A5036502346 @default.
• W4387296852 creator A5054128383 @default.
• W4387296852 creator A5063507682 @default.
• W4387296852 creator A5082870470 @default.
• W4387296852 creator A5083014289 @default.
• W4387296852 creator A5084391674 @default.
• W4387296852 creator A5085233379 @default.
• W4387296852 date "2023-10-03" @default.
• W4387296852 modified "2023-10-16" @default.
• W4387296852 title "Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events" @default.
• W4387296852 cites W1918196193 @default.
• W4387296852 cites W1923600032 @default.
• W4387296852 cites W1966714873 @default.
• W4387296852 cites W1996692474 @default.
• W4387296852 cites W2033563274 @default.
• W4387296852 cites W2034556696 @default.
• W4387296852 cites W2043241676 @default.
• W4387296852 cites W2046481528 @default.
• W4387296852 cites W2050118439 @default.
• W4387296852 cites W2069340435 @default.
• W4387296852 cites W2069490525 @default.
• W4387296852 cites W2107328434 @default.
• W4387296852 cites W2120959053 @default.
• W4387296852 cites W2127261816 @default.
• W4387296852 cites W2136587191 @default.
• W4387296852 cites W2139704316 @default.
• W4387296852 cites W2144086544 @default.
• W4387296852 cites W2144641374 @default.
• W4387296852 cites W2160629168 @default.
• W4387296852 cites W2181908888 @default.
• W4387296852 cites W2279209513 @default.
• W4387296852 cites W2339029337 @default.
• W4387296852 cites W2508221593 @default.
• W4387296852 cites W2533466707 @default.
• W4387296852 cites W2612940703 @default.
• W4387296852 cites W2732223081 @default.
• W4387296852 cites W2909115608 @default.
• W4387296852 cites W2959442417 @default.
• W4387296852 cites W2977660163 @default.
• W4387296852 cites W2996679936 @default.
• W4387296852 cites W3010844055 @default.
• W4387296852 cites W3126965685 @default.
• W4387296852 cites W4225811377 @default.
• W4387296852 cites W4235572931 @default.
• W4387296852 cites W4246476624 @default.
• W4387296852 cites W4247527442 @default.
• W4387296852 cites W4295793971 @default.
• W4387296852 doi "https://doi.org/10.1001/jama.2023.17465" @default.
• W4387296852 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37787793" @default.
• W4387296852 hasPublicationYear "2023" @default.
• W4387296852 type Work @default.
• W4387296852 citedByCount "0" @default.
• W4387296852 crossrefType "journal-article" @default.
• W4387296852 hasAuthorship W4387296852A5004568141 @default.
• W4387296852 hasAuthorship W4387296852A5004937795 @default.
• W4387296852 hasAuthorship W4387296852A5005472573 @default.
• W4387296852 hasAuthorship W4387296852A5005538880 @default.
• W4387296852 hasAuthorship W4387296852A5012551681 @default.
• W4387296852 hasAuthorship W4387296852A5015960013 @default.
• W4387296852 hasAuthorship W4387296852A5022592999 @default.
• W4387296852 hasAuthorship W4387296852A5024243963 @default.
• W4387296852 hasAuthorship W4387296852A5029438535 @default.
• W4387296852 hasAuthorship W4387296852A5030022395 @default.
• W4387296852 hasAuthorship W4387296852A5034543902 @default.
• W4387296852 hasAuthorship W4387296852A5036502346 @default.
• W4387296852 hasAuthorship W4387296852A5054128383 @default.
• W4387296852 hasAuthorship W4387296852A5063507682 @default.
• W4387296852 hasAuthorship W4387296852A5082870470 @default.
• W4387296852 hasAuthorship W4387296852A5083014289 @default.
• W4387296852 hasAuthorship W4387296852A5084391674 @default.
• W4387296852 hasAuthorship W4387296852A5085233379 @default.
• W4387296852 hasConcept C126322002 @default.
• W4387296852 hasConcept C168563851 @default.
• W4387296852 hasConcept C1862650 @default.
• W4387296852 hasConcept C197934379 @default.
• W4387296852 hasConcept C2776006263 @default.
• W4387296852 hasConcept C2779547634 @default.
• W4387296852 hasConcept C2780221984 @default.
• W4387296852 hasConcept C44249647 @default.
• W4387296852 hasConcept C535046627 @default.
• W4387296852 hasConcept C71924100 @default.
• W4387296852 hasConcept C82789193 @default.
• W4387296852 hasConcept C95190672 @default.
• W4387296852 hasConceptScore W4387296852C126322002 @default.
• W4387296852 hasConceptScore W4387296852C168563851 @default.

• next